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T he recent decision by the National Institute for Health Re-search to fund a large programme of research and develop-
ment work on dementia syndromes may be a watershed for London’s 
primary care. Evidence-based interventions in dementia (EVIDEM) is a  
five year,  
£2 million, research programme led by primary care which reaches into  
specialist areas, and which contains five projects run by a  
multi-disciplinary group of researchers (See box 1). It is highly unusual in 
that it is a translational programme of applied research, designed to 
change clinical and organisational practice, rather than the traditional 
‘blue skies’ research that academia often prefers. Primary care researchers 
were able to win this programme against formidable competition from 
specialist consortia because of our background in such unfashionable 
applied research, and in doing so demonstrated that often rivalrous  
Universities could collaborate around a coherent R&D programme.  
 
The dementia syndromes are becoming more prevalent as the population 
ages, and will inflate health and social care costs very significantly in the 
next decades1. Their insidious onset, variable presentation and 
progressive course make diagnosis and management problematic2,3  
particularly for primary care professionals who throughout the  
industrialised world struggle with both the recognition of dementia  
syndromes and with tailoring appropriate responses4,5,6,7,8,9 when  
psychosocial support is in short supply. It is hardly surprising that  
dementia care is rising up the policy agenda, with a growing emphasis on 
changing clinical practice likely to find expression in the autumn in the 
Department of Health’s Dementia Strategy.  
 
The inclusiveness of the EVIDEM programme was a winning  
characteristic for the research team, injecting a ‘real life’ dimension to 
research and development by joining together projects along the  
trajectory of the disease process, from diagnosis to end-of-life care. So 
was its base in north London, with its diverse population and often  
fragmented services; if practice can be changed in London, it can be  
anywhere. Links with networks of people with dementia and their carers 
were also crucial in demonstrating public and patient involvement. The 
programme’s host, Central & North West London NHS Foundation 
Trust, reinforced the promise of grounded research and development. 
 
The headiness of success wears off quickly, and the problems of primary 
care research rapidly re-assert themselves. There are many reasons why 
this programme might fail, which is why we think of it as a watershed. 
Such an ambitious programme requires collaboration beyond the inner 
group of researchers and institutions, for it will test the usefulness of  
research networks; the interest of provider Trusts in research,  
Systems and Organisations 
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the collegiality of specialists; the ability of the re-
search bureaucracy to facilitate wide-scale R&D in 
the community; and the engagement of  
general practitioners (amongst others e.g. district 
nurses, care home staff) in activities without  
instant yield.   
 
RESEARCH NETWORKS 
EVIDEM seeks to recruit a cohort of 2,000 people 
with dementia and their carers, over a five year 
period. Most people with dementia are living at 
home, and their main source of medical care is 
their general practitioner. In theory we should be 
able to identify people with dementia through their 
general practices, a task made easier by the QOF 
requirement to keep a register. In practice there are 
multiple obstacles to recruiting through general 
practice, and two recent dementia trials that  
attempted to do so struggled to reach their  
recruitment targets10,11. The QOF requirement may 
have changed this and made it easier to identify 
people with dementia, and so we will work with 
the Primary Care Research Network for Greater 
London (PCRN-GL) to test this. Nevertheless to 
accrue people with dementia at the speed we need 
(400 consenting to join a cohort each year) we will 
have to rely, at least initially, on recruitment 
through memory clinics and outpatient clinics. 
This means having a working relationship with the 
Dementias and Neurodegenerative Diseases  
Research Network (DeNDRoN) in North 
Thames. 
 
The Dementia & Neurodegenerative Diseases  
Research Network (DeNDRoN) has developed 
local networks to recruit large numbers of people 
for community-based trials, and it has been clear 
from the outset that primary care researchers will 
have an important role in developing these  
networks, and carrying out the trials12. The  
 
Recognition of & response to dementia in primary care: an RCT of educational 
Interventions ~led by Professor Steve Iliffe (Primary Care at UCL)  
s.iliffe@pcps.ucl.ac.uk 
 
Exercise for Behavioural & Psychological Symptoms in Dementia: a randomized  
controlled trial of exercise as therapy ~ led by Dr James Warner (Old Age 
Psychiatry in Central & NW London NHS Foundation Trust) 
j.warner@imperial.ac.uk 
 
Management of urinary incontinence in the community: developing and testing 
Practitioner toolkits ~ led by Professor Vari Drennan (Health Services Research, 
St. George’s & Kingston University)     vdrennan@hscs.sgul.ac.uk 
 
End of life care in dementia: developing and testing ‘best practice’ guidelines 
~ led by Professor Claire Goodman (Health Services Research, University of 
Hertfordshire)      c.goodman@herts.ac.uk 
 
Evaluating the implementation of the Mental Capacity Act 2005: ~ led by 
Professor Jill Manthorpe (Social Work, King’s College London) 
jill.manthorpe@kcl.ac.uk 
 
Cohort development ~ led by Dr. Greta Rait (Primary Care at UCL) 
 
Statistics & trial design ~ led by Mark Griffin (Primary care at UCL) 
 
Health Economics ~ led by Professor Martin Knapp, (LSE) 
 
Box 1 The EVIDEM team and projects 
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argument that primary care research on new  
diagnostic tools and therapeutic interventions, and 
on the use of clinical signs and symptoms to  
estimate prognosis and select the appropriate  
interventions, is crucial to understanding and  
improving care for this group has been well made, 
but putting it into practice may be more difficult.  
 
COLLEGIALITY 
Researchers from specialist backgrounds all too 
often see primary care as a source of ‘research  
material’ rather than a source of research  
partnership. A programme led from primary care 
that encroaches on specialist domains and recruits 
through specialist sites reverses the usual order, 
and may need some negotiation. This test of  
specialist collegiality will be felt strongly in the host 
Trust, which now has a legal obligation to deliver 
the research programme without interfering with 
its much greater commitment to service provision. 
Practitioners with busy jobs, or who are  
disgruntled by re-engineering of services and  
re-writing of job descriptions, will need to be  
persuaded of the merits of recruiting patients to a 
cohort. It is not just general practitioners who feel 
so busy that clinical tasks squeeze out all other  
interests. Since the projects within the EVIDEM 
programme are translational, with as much  
evidence on development as on research,  
implementing their findings will be a test of the 
roles of organisational culture, leadership, and 
evaluation in research utilization14. Here too there 
is a watershed, for as long as efficacy and  
effectiveness trials are considered complete  
without considering implementation in  
non-research settings, the public health potential 
of the original investments will not be realized. 
The EVIDEM programme will utilise and also test, 
models for translating research into practice  
derived from theories about the diffusion of  
innovations15, models of change in service  
delivery16,17,18 and measures of the  
population-based effectiveness of translation19. 
 
WORKLOAD PRESSURES  
Dementia is not core business for many general 
practitioners, regardless of QOF incentives, and 
there is some evidence that as a discipline they feel 
unskilled in working with people who are  
cognitively impaired. This evidence, based on  
reports from the Audit Commission20 and the  
National Audit Office21, is probably overstated.  
The core skills required for working with patients 
with dementia are already present in the  
discipline22, and the construction of meanings,  
dialogue about explanatory models of illness and 
the search for shared understanding that are  
necessary in dementia care are also part of the  
expertise of general practice23. General  
practitioners are highly regarded by families of 
people with dementia24 because they provide  
continuity of care across the whole trajectory of 
the disease, have established relationships of trust, 
act as advocates and problem-solvers when other 
agencies fail to do so, and open the gate to other 
sources of help. We will rely on these  
characteristics to recruit to the EVIDEM cohort 
through general practice, albeit at a slower rate 
than we can through DeNDRoN. 
 
RESEARCH BUREAUCRACY 
Researchers now have to work their way through a 
multitude of organisations before a single person 
can be recruited. Trusts weighed down with the 
administration of clinical services have to find 
space and time to manage unfamiliar research  
contracts, full of issues about ownership of  
knowledge and responsibility for governance and 
probity. Ethics committees have to reach  
judgements about approaching people who might 
be deemed vulnerable to seek their engagement 
with research, and take the job seriously but also 
differently in different places. Research governance 
offices in PCTs require their own forms completed 
and their own criteria to be satisfied before  
approval can be given for research to proceed. 
Practitioners can add their understandings and 
misunderstandings to discussions about rights of 
access to clinical information, ownership of data, 
and the ethics of inviting cognitively impaired  
people to participate in research. A mood of risk 
aversion permeates the research bureaucracy, and 
at times this can paralyse research activity. Against 
this we will argue that involvement in research  
improves outcomes for patients that protecting 
people with dementia from the opportunity to join 
research projects is a denial of their human rights, 
and that research and development are essential 
for clinical services if they are to flourish rather 
than merely survive.  In five years time we will 
know if we have won the arguments.    
 
DEMENTIA: STIGMA & TABOO  
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Perhaps the biggest obstacle to the programme is 
the condition being researched. Loss of cognition 
can be so devastating, and so wrapped around with 
stigma and taboo, that we may not be able to  
engage people on the scale that we hope. The  
progressive nature of cognitive losses may make 
consent difficult to achieve and renew over time, 
making us reliant on assent from others, and  
therefore more cautious in how we study people 
and their experiences. However, experience-based 
design, in which the traditional view of the user as 
a passive recipient of a product or service has  
begun to give way to the new view of users as  
integral to the improvement and innovation  
process25, is at the centre of the EVIDEM  
programme. There are signs that the concerns 
about engaging people with dementia in research 
are also exaggerated, and that they and their carers 
will understand the benefits of being involved in 
research, take the opportunity to advance 
knowledge for others’ benefits rather than their 
own, and demonstrate that they are engaged  
citizens, just like us.   
 
In five years time we will know which way this  
research is flowing, and a lot more about the 
potential for large-scale applied research in 
primary care in London. We look forward to 
reporting the lessons, positive and negative, in 
this journal.  Primary care professionals who are 
interested in contributing to the EVIDEM  
programme are welcome to contact us. We 
would particularly like to hear  from: general  
practitioners, and practice and community 
nurses who are interested in diagnosis of  
dementia; from community nurses and social 
workers about incontinence management; from 
care home practitioners interested in BPSD 
management and end-of-life care; and from all 
staff trying to understand the implications of the 
Mental Capacity Act 2005.  
 
To get in touch with the EVIDEM programme 
contact David Lowery (CNWL NHS  
Foundation Trust) d.lowery@nhs.net  020-3214-
5889 or  
Kalpa Kharicha (Primary Care at UCL) 
k.kharicha@pcps.ucl.ac.uk, 0207-830-2392 
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